Small cell lung cancer.
作者信息
Leonard R C
机构信息
University Department of Clinical Oncology, Western General Hospital, Edinburgh, UK.
出版信息
Br J Cancer. 1989 Apr;59(4):487-90. doi: 10.1038/bjc.1989.101.
Abstract
摘要
相似文献
1
Small cell lung cancer.小细胞肺癌
Br J Cancer. 1989 Apr;59(4):487-90. doi: 10.1038/bjc.1989.101.
2
The role of cisplatin in the treatment of small-cell lung cancer?顺铂在小细胞肺癌治疗中的作用？
Ann Oncol. 2001 May;12(5):585-6. doi: 10.1023/a:1011157008014.
3
Prophylactic cranial irradiation in small-cell lung cancer.小细胞肺癌的预防性颅脑照射
N Engl J Med. 2007 Nov 8;357(19):1977-8; author reply 1978.
4
Duration of chemotherapy in small cell lung cancer.小细胞肺癌的化疗疗程
Thorax. 1990 Jan;45(1):1-2. doi: 10.1136/thx.45.1.1.
5
[Role of systemic chemotherapy in smalL cell lung cancer as a part of multidisciplinary treatment].
Rinsho Hoshasen. 1985 Mar;30(3):401-2.
6
Chemotherapy advances in small cell lung cancer.小细胞肺癌的化疗进展
Ann Oncol. 2006 May;17 Suppl 5:v99-102. doi: 10.1093/annonc/mdj961.
7
Diseases desperate grown.病入膏肓。
J Natl Cancer Inst. 2008 Apr 16;100(8):520-1. doi: 10.1093/jnci/djn082. Epub 2008 Apr 8.
8
Should maintenance chemotherapy be used to treat small cell lung cancer?是否应该使用维持化疗来治疗小细胞肺癌？
Eur J Cancer. 1998 Jul;34(8):1148-55. doi: 10.1016/s0959-8049(98)00081-1.
9
Chemotherapy of small cell lung cancer.小细胞肺癌的化疗
Eur J Cancer. 1991;27(3):342-9. doi: 10.1016/0277-5379(91)90543-m.
10
[Chemotherapy for small cell lung cancer].
Nihon Kokyuki Gakkai Zasshi. 2004 May;42(5):399-403.
引用本文的文献
1
Indium-111 pentetreotide in the diagnostic work-up of patients with bronchogenic carcinoma.铟-111 五肽胃泌素在支气管源性癌患者诊断检查中的应用
Eur J Nucl Med. 1994 Dec;21(12):1318-25. doi: 10.1007/BF02426696.
2
Is the progress in cancer treatment results adequate or are we confronted with a more or less worldwide stagnation.癌症治疗结果的进展是否足够，还是说我们或多或少面临着全球范围内的停滞？
J Cancer Res Clin Oncol. 1990;116(5):425-30. doi: 10.1007/BF01612987.
3
A Medical Research Council phase II trial of alternating chemotherapy and radiotherapy in small-cell lung cancer. The Medical Research Council Lung Cancer Working Party.医学研究委员会开展的一项小细胞肺癌化疗与放疗交替进行的II期试验。医学研究委员会肺癌工作组。
Br J Cancer. 1991 Oct;64(4):775-9. doi: 10.1038/bjc.1991.397.
4
Treatment of relapse of small cell lung cancer in selected patients with the initial combination chemotherapy carboplatin, etoposide, and epirubicin.对部分小细胞肺癌复发患者采用初始联合化疗方案（卡铂、依托泊苷和表柔比星）进行治疗。
Thorax. 1992 May;47(5):369-71. doi: 10.1136/thx.47.5.369.
本文引用的文献
1
The hospital anxiety and depression scale.医院焦虑抑郁量表。
Acta Psychiatr Scand. 1983 Jun;67(6):361-70. doi: 10.1111/j.1600-0447.1983.tb09716.x.
2
The influence of myelosuppression on the response to chemotherapy in small cell bronchogenic carcinoma.骨髓抑制对小细胞支气管肺癌化疗反应的影响。
Cancer. 1984 Aug 1;54(3):411-5. doi: 10.1002/1097-0142(19840801)54:3<411::aid-cncr2820540307>3.0.co;2-5.
3
Intensive chemoradiotherapy with autologous marrow transplantation for small cell carcinoma of the lung.
Cancer Treat Rep. 1983 Dec;67(12):1055-9.
4
Cisplatin, adriamycin, and etoposide (CAV) for remission induction of small-cell bronchogenic carcinoma.顺铂、阿霉素和依托泊苷（CAV方案）用于小细胞支气管肺癌的缓解诱导治疗。
Cancer. 1982 Aug 15;50(4):652-8. doi: 10.1002/1097-0142(19820815)50:4<652::aid-cncr2820500406>3.0.co;2-8.
5
Alkylating agents in bronchogenic carcinoma.支气管源性癌中的烷化剂。
Am J Med. 1969 Apr;46(4):516-25. doi: 10.1016/0002-9343(69)90071-0.
6
Who should measure quality of life, the doctor or the patient?应该由谁来衡量生活质量，医生还是患者？
Br J Cancer. 1988 Jan;57(1):109-12. doi: 10.1038/bjc.1988.20.
7
Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer.广泛期小细胞肺癌采用晚期强化联合治疗模式并继以自体骨髓输注
J Clin Oncol. 1986 Oct;4(10):1443-54. doi: 10.1200/JCO.1986.4.10.1443.
8
Small-cell lung cancer--whither late intensification?小细胞肺癌——后期强化治疗何去何从？
J Clin Oncol. 1986 Oct;4(10):1437-8. doi: 10.1200/JCO.1986.4.10.1437.
9
10
High-dose cyclophosphamide and VP 16 as late dosage intensification therapy for small cell carcinoma of lung.
Cancer Chemother Pharmacol. 1985;15(3):303-6. doi: 10.1007/BF00263906.
Zotero 插件